Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary

Por Samardzija, Chantel, Quinn, Michael, Findlay, Jock K, Ahmed, Nuzhat
Publicado em 2012

Estrogen-Dependent Gene Expression in the Mouse Ovary

Por Liew, Seng H., Sarraj, Mai A., Drummond, Ann E., Findlay, Jock K.
Publicado em 2011

The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression

Por Escalona, Ruth M., Chan, Emily, Kannourakis, George, Findlay, Jock K., Ahmed, Nuzhat
Publicado no Int J Mol Sci (2018)

Identification and cloning of two isoforms of human high-temperature requirement factor A3 (HtrA3), characterization of its genomic structure and comparison of its tissue distribut...

Por Nie, Gui-Ying, Hampton, Anne, Li, Ying, Findlay, Jock K, Salamonsen, Lois A
Publicado em 2003

Neuronal transcription factor Brn-3a(l) is over expressed in high-grade ovarian carcinomas and tumor cells from ascites of patients with advanced-stage ovarian cancer

Por Ahmed, Nuzhat, Latifi, Ardian, Riley, Clyde B, Findlay, Jock K, Quinn, Michael A
Publicado em 2010

Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer

Por Chan, Emily, Luwor, Rodney, Burns, Christopher, Kannourakis, George, Findlay, Jock K., Ahmed, Nuzhat
Publicado no Oncotarget (2018)

The ovarian reserve is depleted during puberty in a hormonally driven process dependent on the pro-apoptotic protein BMF

Por Liew, Seng H, Nguyen, Quynh-Nhu, Strasser, Andreas, Findlay, Jock K, Hutt, Karla J
Publicado no Cell Death Dis (2017)

A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer

Por Samardzija, Chantel, Luwor, Rodney B, Volchek, Mila, Quinn, Michael A, Findlay, Jock K, Ahmed, Nuzhat
Publicado no Mol Cancer (2015)

Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer

Por Samardzija, Chantel, Luwor, Rodney B., Quinn, Michael A., Kannourakis, George, Findlay, Jock K., Ahmed, Nuzhat
Publicado no BMC Cancer (2016)

HTRA3 expression in non-pregnant rhesus monkey ovary and endometrium, and at the maternal-fetal interface during early pregnancy

Por Bowden, Marissa A, Li, Ying, Liu, Yi-Xun, Findlay, Jock K, Salamonsen, Lois A, Nie, Guiying
Publicado em 2008

Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells

Por Ahmed, Nuzhat, Greening, David, Samardzija, Chantel, Escalona, Ruth M., Chen, Maoshan, Findlay, Jock K., Kannourakis, George
Publicado no Sci Rep (2016)

TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells

Por Escalona, Ruth M., Bilandzic, Maree, Western, Patrick, Kadife, Elif, Kannourakis, George, Findlay, Jock K., Ahmed, Nuzhat
Publicado no BMC Cancer (2020)

Betaglycan Alters NFκB-TGFβ2 Cross Talk to Reduce Survival of Human Granulosa Tumor Cells

Por Bilandzic, Maree, Chu, Simon, Wang, Yao, Tan, Han L., Fuller, Peter J., Findlay, Jock K., Stenvers, Kaye L.
Publicado no Mol Endocrinol (2013)

Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib

Por Kerr, Jeffrey B., Hutt, Karla J., Cook, Michele, Speed, Terence P, Strasser, Andreas, Findlay, Jock K., Scott, Clare L.
Publicado em 2012

Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling

Por Samardzija, Chantel, Greening, David W., Escalona, Ruth, Chen, Maoshan, Bilandzic, Maree, Luwor, Rodney, Kannourakis, George, Findlay, Jock K., Ahmed, Nuzhat
Publicado no Sci Rep (2017)

Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden

Por Abubaker, Khalid, Latifi, Ardian, Luwor, Rod, Nazaretian, Simon, Zhu, Hongjian, Quinn, Michael A, Thompson, Erik W, Findlay, Jock K, Ahmed, Nuzhat
Publicado em 2013

Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor...

Por Abubaker, Khalid, Luwor, Rodney B., Escalona, Ruth, McNally, Orla, Quinn, Michael A., Thompson, Erik W., Findlay, Jock K., Ahmed, Nuzhat
Publicado em 2014

Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden

Por Abubaker, Khalid, Luwor, Rodney B, Zhu, Hongjian, McNally, Orla, Quinn, Michael A, Burns, Christopher J, Thompson, Erik W, Findlay, Jock K, Ahmed, Nuzhat
Publicado em 2014

Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility

Por Nguyen, Quynh-Nhu, Zerafa, Nadeen, Liew, Seng H., Morgan, F. Hamish, Strasser, Andreas, Scott, Clare L., Findlay, Jock K., Hickey, Martha, Hutt, Karla J.
Publicado no Cell Death Dis (2018)

Loss of Betaglycan Contributes to the Malignant Properties of Human Granulosa Tumor Cells

Por Bilandzic, Maree, Chu, Simon, Farnworth, Paul G., Harrison, Craig, Nicholls, Peter, Wang, Yao, Escalona, Ruth M., Fuller, Peter J., Findlay, Jock K., Stenvers, Kaye L.
Publicado no Mol Endocrinol (2009)